Table 3 Results of meta-regression analysis
From: Prevalence of metabolic syndrome in ankylosing spondylitis: a multi national meta-analysis study
Variable | Coefficient (β) | P value | Residual Tau2 | Residual I2 | Residual H2 | R2 |
|---|---|---|---|---|---|---|
Age | 0.04 | < 0.01 | 0.05 | 94.18 | 17.17 | 18.75 |
BMI | 0.09 | < 0.01 | 0.03 | 76.39 | 4.24 | 30.09 |
WC | 0.03 | < 0.01 | 0.00 | 0.00 | 1 | 100 |
ESR | 0.018 | 0.04 | 0.05 | 81.57 | 5.42 | 12.10 |
CRP | -0.01 | 0.12 | 0.03 | 73.71 | 3.80 | 10.91 |
TG | 0.01 | < 0.01 | 0.05 | 78.44 | 4.64 | 37.02 |
TC | 0.01 | 0.05 | 0.11 | 87.67 | 8.11 | 2.93 |
HDL | -0.01 | 0.12 | 0.08 | 84.87 | 6.61 | 0.00 |
LDL | 0.01 | 0.09 | 0.10 | 87.22 | 7.82 | 0.00 |
SBP | < 0.01 | 0.72 | 0.04 | 78.18 | 4.58 | 0.00 |
DBP | 0.04 | 0.02 | 0.02 | 67.63 | 3.09 | 35.25 |
BASDAI | 0.03 | 0.02 | 0.03 | 77.48 | 4.44 | 21.90 |
TNF inhibitors consumption rate | 0.44 | 0.45 | 0.01 | 61.33 | 2.59 | 66.43 |
Duration of the Disease | -0.05 | 0.18 | 0.08 | 86.81 | 7.58 | 0.00 |